I bought a goodly amount of stock in this company recently and came across this article this morning and thought Id share:
"6:00 AM ET 4/13/12 | BusinessWire
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), announced today that it held a meeting with the U.S. Food and Drug Administration (“FDAâ€) in which they discussed the Investigational Device Exemption (“IDEâ€) application previously filed by InVivo for its biopolymer scaffolding to treat acute spinal cord injuries.
........
This is a significant step for all patients waiting for first in-man data using biomaterials for spinal cord injuries,†said Frank Reynolds, InVivo’s Chief Executive Officer. “We are pleased that our core team of multidisciplinary scientists, led by my partner, Bob Langer, has had the opportunity to meet with the FDA to discuss our platform technology. We are encouraged by the communication we have had with the FDA to this point, and pending approval of the IDE, we expect the clinical trial for our treatment of acute spinal cord injuries to commence during thesecond half of 2012."
Heres the link from their site:
http://www.invivotherapeutics.com/20...cord-injuries/
The company definitely doesnt follow the "mainstream" focus on treatment/cures, such as stem cells etc, but theyve been having very good results and are making huge process with the FDA. Geron's Medical Leader, Dr. Edwards, relocated to InVivo shortly before Geron dropped their clinical for SCI and the ceo of the company, Frank Reynolds, is a SCI recoveree who spent several years on his back in bed before being fortunate enough to begin seeing significant recovery. These guys are focused on not only finding a fix, but finding it as soon as they safely can, which is very refreshing.
Im fairly sure they collaborate with the Miami Project as well, but Im a bit fuzzy atm. Anyways, Im stoked to see some serious headway made and clinical trials on human SCI patients to begin in America soon. They will be starting with acute and hoping to move to chronic eventually (as seems to be the standard, as these things go).
Anyways, hope some people find this helpful and Id love to hear Dr. Wise's opinions on this treatment.
"6:00 AM ET 4/13/12 | BusinessWire
InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), announced today that it held a meeting with the U.S. Food and Drug Administration (“FDAâ€) in which they discussed the Investigational Device Exemption (“IDEâ€) application previously filed by InVivo for its biopolymer scaffolding to treat acute spinal cord injuries.
........
This is a significant step for all patients waiting for first in-man data using biomaterials for spinal cord injuries,†said Frank Reynolds, InVivo’s Chief Executive Officer. “We are pleased that our core team of multidisciplinary scientists, led by my partner, Bob Langer, has had the opportunity to meet with the FDA to discuss our platform technology. We are encouraged by the communication we have had with the FDA to this point, and pending approval of the IDE, we expect the clinical trial for our treatment of acute spinal cord injuries to commence during thesecond half of 2012."
Heres the link from their site:
http://www.invivotherapeutics.com/20...cord-injuries/
The company definitely doesnt follow the "mainstream" focus on treatment/cures, such as stem cells etc, but theyve been having very good results and are making huge process with the FDA. Geron's Medical Leader, Dr. Edwards, relocated to InVivo shortly before Geron dropped their clinical for SCI and the ceo of the company, Frank Reynolds, is a SCI recoveree who spent several years on his back in bed before being fortunate enough to begin seeing significant recovery. These guys are focused on not only finding a fix, but finding it as soon as they safely can, which is very refreshing.
Im fairly sure they collaborate with the Miami Project as well, but Im a bit fuzzy atm. Anyways, Im stoked to see some serious headway made and clinical trials on human SCI patients to begin in America soon. They will be starting with acute and hoping to move to chronic eventually (as seems to be the standard, as these things go).
Anyways, hope some people find this helpful and Id love to hear Dr. Wise's opinions on this treatment.
Comment